Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

DOUGLAS KEVIN

2. Date of Event Requiring Statement (MM/DD/YYYY) 5/22/2014

3. Issuer Name and Ticker or Trading Symbol

TRANSGENOMIC INC [TBIO]

(Last) (First) (Middle)

125 E. SIR FRANCIS DRAKE BLVD., STE 400

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director ___ X ___ 10% Owner
_____ Officer (give title below) ___ X ___ Other (specify below)
/ 13(d)(3) group

(Street)

LARKSPUR, CA 94939

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	278332	D ⁽¹⁾ ⁽²⁾
Common Stock	351666	I ⁽²⁾ ⁽³⁾	By James Douglas and Jean Douglas Irrevocable Descendants' Trust
Common Stock	153333	I ⁽²⁾ ⁽⁴⁾	By Douglas Family Trust
Common Stock	33333	I ⁽²⁾ ⁽⁵⁾	By James E. Douglas III

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Warrant (right to buy)	⁽⁶⁾	2/7/2017	Common Stock	85250	$11.73	D ⁽¹⁾ ⁽²⁾
Warrant (right to buy)	⁽⁶⁾	2/7/2017	Common Stock	70332	$11.73	I ⁽²⁾ ⁽³⁾	By James Douglas and Jean Douglas Irrevocable Descendants' Trust
Warrant (right to buy)	⁽⁶⁾	2/7/2017	Common Stock	36231	$11.73	I ⁽²⁾ ⁽⁴⁾	By Douglas Family Trust
Warrant (right to buy)	⁽⁶⁾	2/7/2017	Common Stock	21312	$11.73	I ⁽²⁾ ⁽⁵⁾	By James E. Douglas III

Explanation of Responses:
( 1)	These shares are held directly and jointly by Kevin Douglas and his wife, Michelle Douglas.
( 2)	Each of the reporting persons hereunder (individually, a "Reporting Person" and collectively the "Reporting Persons") may be deemed a member of a "group" within the meaning of Section 13(d)(3) of the Securities and Exchange Act of 1934, as amended (the "Exchange Act") or Rule 13d-5 promulgated under the Exchange Act, with one or more of the other Reporting Persons. Although the Reporting Persons are reporting such securities as if they were members of a "group", the filing of this Form 3 shall not be deemed an admission by any Reporting Person that such Reporting Person is a beneficial owner of any securities other than those directly held by such Reporting Person.
( 3)	These shares are held directly by the James Douglas and Jean Douglas Irrevocable Descendants' Trust and indirectly by Kevin Douglas and Michelle Douglas. Kevin Douglas and Michelle Douglas, husband and wife, are each a co-trustee of the James Douglas and Jean Douglas Irrevocable Descendants' Trust.
( 4)	These shares are held directly by the Douglas Family Trust and indirectly by Kevin Douglas. James E. Douglas, Jr. and Jean A. Douglas, husband and wife, are each a co-trustee of the Douglas Family Trust.
( 5)	These shares are held directly by James E. Douglas, III and indirectly by Kevin Douglas.
( 6)	This warrant is exercisable at any time up to and including the expiration date. The terms of this warrant contain a limitation on conversion which prevents the Reporting Person from converting this warrant into shares without the issuer's prior approval, if, after giving effect to the conversion, the Reporting Person would beneficially own more than 9.99% of the issuer's outstanding shares.

Remarks:
Exhibit 24. Limited Power of Attorney

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
DOUGLAS KEVIN 125 E. SIR FRANCIS DRAKE BLVD., STE 400 LARKSPUR, CA 94939		X		13(d)(3) group
Douglas Michelle 125 E. SIR FRANCIS DRAKE BLVD., STE 400 LARKSPUR, CA 94939		X		13(d)(3) group
DOUGLAS FAMILY TRUST 125 E. SIR FRANCIS DRAKE BLVD., STE 400 LARKSPUR, CA 94939		X		13(d)(3) group
JAMES & JEAN DOUGLAS IRREVOCABLE DESCENDANTS TRUST 125 E. SIR FRANCIS DRAKE BLVD., STE 400 LARKSPUR, CA 94939		X		13(d)(3) group
DOUGLAS JAMES E III 125 E. SIR FRANCIS DRAKE BLVD., STE 400 LARKSPUR, CA 94939		X		13(d)(3) group

Signatures
/s/ Eileen Wheatman, attorney in fact for Kevin Douglas		5/29/2014
^** Signature of Reporting Person		Date
/s/ Eileen Wheatman, attorney in fact for Michelle Douglas		5/29/2014
^** Signature of Reporting Person		Date
/s/ Eileen Wheatman, attorney in fact for Douglas Family Trust		5/29/2014
^** Signature of Reporting Person		Date
/s/ Eileen Wheatman, attorney in fact for James Douglas and Jean Douglas Irrevocable Descendants' Trust		5/29/2014
^** Signature of Reporting Person		Date
/s/ Eileen Wheatman, attorney in fact for James E. Douglas III		5/29/2014
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.